---
figid: PMC5877395__12929_2018_430_Fig1_HTML
figtitle: Annexin A2 (ANXA2) in cancer progression
organisms:
- NA
pmcid: PMC5877395
filename: 12929_2018_430_Fig1_HTML.jpg
figlink: /pmc/articles/PMC5877395/figure/Fig1/
number: F1
caption: Annexin A2 (ANXA2) in cancer progression. a The ANXA2-3-phosphoglycerate
  kinase (ANXA2-PGK) complex serves as a primer recognition protein to initiate DNA
  replication with the support from DNA polymerase alpha, which contributes to cell
  proliferation. b MIEN1 phosphorylates ANXA2 and supports ANXA2’s binding to actin
  filaments to modulate cytoskeletal change, thus resulting in cell migration. c ANXA2
  initiates the endothelial-mesenchymal transition (EMT) via the Twist/Snail pathway.
  After initiation of the EMT, cells changed to a mesenchymal-like morphology, and
  cell junctions dissolved. d The ANXA2 heterotetramer complex links to the plasminogen
  and tissue plasminogen activator (tPA). After plasminogen is cleaved into plasmin,
  plasmin activates pro-matrix metalloproteases (MMPs) to become MMPs. MMPs digest
  the extracellular matrix and fibronectin, thus resulting acceleration of invasion.
  e ANXA2 increases stemness-related transcription factors (Oct4, Sox2, and Nanog)
  through the Akt signaling pathway, which activates cancer stem cell formation
papertitle: Annexin A2-mediated cancer progression and therapeutic resistance in nasopharyngeal
  carcinoma.
reftext: Chang-Yu Chen, et al. J Biomed Sci. 2018;25:30.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9561524
figid_alias: PMC5877395__F1
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC5877395__F1
ndex: e4253432-dee2-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5877395__12929_2018_430_Fig1_HTML.html
  '@type': Dataset
  description: Annexin A2 (ANXA2) in cancer progression. a The ANXA2-3-phosphoglycerate
    kinase (ANXA2-PGK) complex serves as a primer recognition protein to initiate
    DNA replication with the support from DNA polymerase alpha, which contributes
    to cell proliferation. b MIEN1 phosphorylates ANXA2 and supports ANXA2’s binding
    to actin filaments to modulate cytoskeletal change, thus resulting in cell migration.
    c ANXA2 initiates the endothelial-mesenchymal transition (EMT) via the Twist/Snail
    pathway. After initiation of the EMT, cells changed to a mesenchymal-like morphology,
    and cell junctions dissolved. d The ANXA2 heterotetramer complex links to the
    plasminogen and tissue plasminogen activator (tPA). After plasminogen is cleaved
    into plasmin, plasmin activates pro-matrix metalloproteases (MMPs) to become MMPs.
    MMPs digest the extracellular matrix and fibronectin, thus resulting acceleration
    of invasion. e ANXA2 increases stemness-related transcription factors (Oct4, Sox2,
    and Nanog) through the Akt signaling pathway, which activates cancer stem cell
    formation
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PLG
  - HADHA
  - PLAT
  - CDH2
  - PLA2G4A
  - KAT5
  - ANXA2
  - ITK
  - SLC22A3
  - TWIST1
  - SNAI1
  - S100A10
  - POU5F1
  - POU5F1P3
  - POU5F1P4
  - AKT1
  - AKT2
  - AKT3
  - SOX2
  - MIEN1
  - BSG
  - NANOG
  - ACTA1
  - ACTA2
  - ACTB
  - ACTC1
  - ACTG1
  - ACTG2
  - SNAI2
  - SNAI3
  - COL1A1
  - COL1A2
  - Cancer
---
